{"schema_version":"secwatch.filing_event.v1","accession":"0000310764-21-000108","form_type":"8-K","ticker":"SYK","cik":"0000310764","company_name":"STRYKER CORP","filed_at":"2021-07-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:20.262531+00:00","generated_at":"2026-06-30T02:18:24.579994+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Stryker Q2 net sales $4.3B (+55% YoY), raises FY2021 guidance","bullets":["Reported net sales $4.3B, +55.4% from 2020 and +17.6% from 2019; organic net sales +42.9% from 2020.","Reported EPS $1.55; adjusted EPS $2.25 (up from $0.64 in Q2 2020).","Adjusted operating income margin 25.9% vs reported 17.0%.","Orthopaedics $1.6B (+82.3%), MedSurg $1.7B (+32.3%), Neuro/Spine $0.9B (+66.9%) from 2020.","Raises FY2021 outlook: organic net sales growth 9-10% from 2019; adj. EPS $9.25-$9.40."],"urls":{"canonical":"https://secwatch.observer/filing/0000310764-21-000108","json":"https://secwatch.observer/filing/0000310764-21-000108.json","markdown":"https://secwatch.observer/filing/0000310764-21-000108.md","text":"https://secwatch.observer/filing/0000310764-21-000108.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310764/000031076421000108/0000310764-21-000108-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310764/000031076421000108/syk-20210727.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T02:18:24.579994+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}